Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide.
Standard Biotools stock last closed at $2.21, down 3.07% from the previous day, and has increased 6.76% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.12 percentage points. Standard Biotools stock is currently +140.22% from its 52-week low of $0.92, and -16.6% from its 52-week high of $2.65.
At the moment, there are 78.38M LAB shares outstanding. The market cap of LAB is $173.23M. In the past 24 hours, 222,311 LAB shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy LAB shares.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by opening an account with eToro today.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal information so you are able to buy LAB today.
Now that you have opened your account on the best stock trading app, your next step is to transfer the money for your investment:
Watch the video below for more details depositing funds into your new brokerage account.
Once you have figured out the best place to buy Standard Biotools stock, it's crucial to evaluate their stock before you invest, so you actually comprehend the risk and upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on LAB's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge LAB's fair value.
You can do more valuation analysis on LAB's stock here.
Last year, LAB revenue was $96.56M. During the last 5 year, LAB's revenue has increased by -1.02% per year. This was slower than the Diagnostics & Research industry average of 15.19%.
Find out more about LAB's earnings and revenue performance here.
In the past year, insiders at LAB have bought more shares than they have sold.
Jeffrey G. Black, SVP Chief Financial Officer of LAB, was the latest LAB insider to buy. They bought $97,221.70 worth of LAB stock on May 19, 2023.
Learn more about who owns LAB stock here.
No, Standard Biotools doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two main order types:
Click the Open button and eToro will place your order.
If you need more assistance buying stocks on eToro, click the how to video below:
Now that you own some LAB stock, you'll want to keep up with your stock purchase.
Start a watchlist to track your LAB stock.
To summarize, here are the 6 steps for buying Standard Biotools stock:
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Standard Biotools, hit the button below to create your watchlist.